|
ARF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.528200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.418400E-02 |
| Normal-vs-Stage2 |
4.950600E-01 |
| Normal-vs-Stage3 |
7.333600E-01 |
| Normal-vs-Stage4 |
5.801400E-01 |
| Stage1-vs-Stage2 |
7.203000E-01 |
| Stage1-vs-Stage3 |
1.507210E-01 |
| Stage1-vs-Stage4 |
9.324400E-01 |
| Stage2-vs-Stage3 |
4.016000E-01 |
| Stage2-vs-Stage4 |
8.786800E-01 |
| Stage3-vs-Stage4 |
4.222200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.325750E-01 |
| Normal-vs-AfricanAmerican |
6.336800E-01 |
| Normal-vs-Asian |
8.028600E-01 |
| Caucasian-vs-AfricanAmerican |
5.268200E-01 |
| Caucasian-vs-Asian |
4.890400E-01 |
| AfricanAmerican-vs-Asian |
6.403800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.673600E-02 |
| Normal-vs-Female |
2.503800E-01 |
| Male-vs-Female |
7.055600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.333600E-01 |
| Normal-vs-Extreme_Weight |
1.154030E-02 |
| Normal-vs-Obese |
9.980800E-01 |
| Normal-vs-Extreme_Obese |
4.457800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.638800E-01 |
| Normal_Weight-vs-Obese |
3.080800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.250200E-01 |
| Extreme_Weight-vs-Obese |
4.091900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.451800E-01 |
| Obese-vs-Extreme_Obese |
7.379800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.745430E-01 |
| Normal-vs-Age(41-60Yrs) |
9.285800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.640370E-02 |
| Normal-vs-Age(81-100Yrs) |
4.656400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.954760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.694110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.212800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.903900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.469400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.318200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.063200E-01 |
| Normal-VS-Type2 PRCC |
1.145180E-01 |
| Normal-VS-KIRP CIMP |
2.848600E-01 |
| Normal-VS-Unclassified PRCC |
2.722200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.600400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.481430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.279700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.328400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.980400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.093000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.714100E-02 |
| Normal-vs-N1 |
5.551600E-01 |
| Normal-vs-N2 |
4.017000E-03 |
| N0-vs-N1 |
8.398500E-02 |
| N0-vs-N2 |
3.606100E-02 |
| N1-vs-N2 |
2.543600E-01 |
|
|
